ACADIA Pharma (ACAD): Narxning sotuvga nisbati
Nevrologik dori vositalari savdosidan olingan barqaror pul oqimi tadqiqot va ishlanmalar (R&D) investitsiyalarini to'liq qoplaydi, bu esa ACADIA Pharmaceuticals (ACAD) uchun likvidlikni ta'minlaydi. Ushbu tarixiy P/S grafigi daromadga nisbatan biznesning baholanish dinamikasini aks ettiradi, bunda ko'rsatkich 2.60 darajasida mustahkamlandi. Samaradorlikning oshishi sun'iy intellekt asosidagi dori vositalarini kashf qilish avtomatizatsiyasi hisobiga yuz bermoqda, tor doiradagi bozorning barqarorligi esa AQShdagi ichki dori ishlab chiqarish orqali qo'llab-quvvatlanmoqda.
%20P%2FS%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261113&filename=GURU_Markets_-_ACAD_-_ACADIA-Pharmaceuticals_-_PS-Multiple "ACAD - ACADIA Corp Bozor kapitallashuvining daromadga nisbati 04.07.2022 - 13.11.2026 oraligʻida | 👁️GURU.Markets👁️")
ACADIA Pharmaceuticals Inc (ACAD) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Barcha qarzlarning o‘z mablag‘lariga nisbati ACADIA Pharmaceuticals|ACAD - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati ACADIA Corp|ACAD - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar ACADIA Pharmaceuticals Inc|ACAD - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari ACADIA Pharmaceuticals|Shoshilinch likvidlik acadia-pharm.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
ACAD - Sof daromad|Prognoz qilingan kelajakdagi foyda ACADIA Pharmaceuticals|ACAD - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning kelajakdagi foydaga nisbati ACADIA Pharma|ACAD - PEG multiplikatori|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati ACADIA Pharmaceuticals Inc|ACAD - EBITDA operatsion foydasi|So'nggi 12 oy davomida bir aksiya uchun sof foyda ACADIA Pharmaceuticals|ACAD - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi acadia-pharm.com|ACAD - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi ACADIA Pharmaceuticals
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning umumiy tahlili:ACAD acadia-pharm.com
P/S koeffitsiyenti biznesning bozor qiymatini uning yillik savdo hajmi bilan nisbatda belgilaydi, bu esa moliyaviy hisobotlar e'lon qilinishidan oldin aktivning haddan tashqari qimmat baholanganligini baholash imkonini beradi. ACADIA Pharmaceuticals (ACAD) kompaniyasining P/S darajasini tahlil qilish orqali investor bozor kapitalizatsiyasini neyropsixiatrik dori vositalarining taqsimot samaradorligi bilan solishtiradi, bunda logistikani optimallashtirish bevosita daromadga ta'sir qiladi va joriy fond bozoridagi qiymatni asoslaydi.
Raqobatdosh kompaniyalar
BIIB (biogen.com) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Neurocrine Biosciences, Inc. NBIX|RGC (Regencell Bioscience Ltd) - Narxning sotuvga nisbati|Axsome Therapeutics Inc - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati XENE (Xenon Corp)|VKTX: P/S multiplikatori|supernus.com (SUPN) - P/S multiplikatori|Narxning daromadga nisbati Catalyst Pharmaceuticals, Inc.|DNLI: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Harmony Pharma (HRMY)|Kapitalizatsiyaning daromadga nisbati Biohaven Corp BHVN|P/S multiplikatori AMLX (Amylyx Pharmaceuticals)|P/S multiplikatori trevitherapeutics.com TRVI|Praxis Precision Medicines, Inc. - P/S multiplikatori|Anavex (AVXL) - Kapitalizatsiyaning daromadga nisbati|CBLL: P/S multiplikatori|Sotuvga nisbatan narx Prothena Corp (PRTA)|Kapitalizatsiyaning daromadga nisbati ALEC|P/S multiplikatori annexonbio.com|Kapitalizatsiyaning daromadga nisbati OMER (Omeros Corporation)|Kapitalizatsiyaning sotish hajmiga nisbati NGNE|P/S multiplikatori ACIU (AC Immune Corp)|Narx/daromad koeffitsiyenti Voyager Corp (VYGR)|Neumora Therapeutics - P/S multiplikatori|scilexholding.com (SCLX) - Kapitalizatsiyaning daromadga nisbati|TVGN: P/S multiplikatori|Alpha Cognition Inc. (ACOG) - P/S multiplikatori|Narxning daromadga nisbati Cognition Therapeutics, Inc.|Narxning daromadga nisbati IKT|Narxning daromadga nisbati Cassava Sciences, Inc. (SAVA)|Narx/daromad koeffitsiyenti assertiotx.com|P/S multiplikatori COYA (Coya Therapeutics)|P/S multiplikatori VistaGen Therapeutics, Inc. VTGN|Ovid Rx - P/S multiplikatori|Acumen Pharmaceuticals, Inc (ABOS) - Kapitalizatsiyaning daromadga nisbati|CRVO: P/S multiplikatori|Alterity Therapeutics Limited (ATHE) - P/S multiplikatori|CLNN (Clene Inc) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati PEPG (PepGen Corp)|Narxning daromadga nisbati Jupiter Neurosciences (JUNS)|Relmada Corp - Kapitalizatsiya va daromad nisbati|P/S multiplikatori ANVS (Annovis Bio, Inc.)|Grace Therapeutics Inc (GRCE) - Sotuvga nisbatan narx|AIFF: Kapitalizatsiyaning daromadga nisbati|KLTO - P/S multiplikatori|neurosense-tx.com (NRSN) - Narxning daromadga nisbati|Reviva Pharmaceuticals, Inc. - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati MetaVia Inc.|Sotuvga nisbatan narx neuraxis.com NRXS|P/S multiplikatori HSDT|P/S multiplikatori passagebio.com (PASG)|P/S multiplikatori NEUP (Neuphoria Therapeutics)|NERV - Kapitalizatsiyaning daromadga nisbati|Athira Pharma, Inc. - P/S multiplikatori|ADXN - P/S multiplikatori|ALZN: P/S multiplikatori|Kapitalizatsiya va daromad nisbati CYCN|PTIX (Protagenic Therapeutics Inc.) - P/S multiplikatori|Pasithea (KTTA) - Narx/daromad koeffitsiyenti|P/S multiplikatori CRGT|P/S multiplikatori avenuetx.com (ATXI)|BrainStorm Cell Therapeutics - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati CARA|CHRO - Narxning daromadga nisbati|Narxning sotuvga nisbati ELYM|ITCI: P/S multiplikatori|longboardpharma.com - Bozor kapitallashuvining daromadga nisbati|MRNS (Marinus Pharmaceuticals, Inc.) - P/S multiplikatori|P/S multiplikatori NKGen Biotech Inc|Narxning daromadga nisbati NeuroBo (NRBO)|SAGE (Sage Therapeutics Inc) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Synaptogenix, Inc. SNPX|TRVN - Kapitalizatsiyaning daromadga nisbati|Vigil Neuro - P/S multiplikatori|WENA - P/S multiplikatori|CERE: P/S multiplikatori
